Aim-To determine the effects of a three month course of low dose cyclosporin on the expression of epidermal cell adhesion molecules. Methods-Eighteen patients with psoriasis were treated for 12 weeks with either 2*5 or 5 mg/kglday of oral cyclosporin.
Methods Eighteen patients with chronic plaque psoriasis were treated with a 12 week course of cyclosporin capsules at a dose of either 2-5 mg/kg/day (n = 7) or 5 mg/kg/day (n = 12). The corresponding mean (SD) trough concentrations of whole blood cyclosporin were 71 (20) and 132 (13) 
QUANT1TATION
Cells expressing each antigen were counted within an area of the section delineated by marks made with indelible ink on the overlying coverslip. Cells were counted if circumferential staining for CD29 was shown. Cells with dendritic morphology positive for CD1 8 were counted ( fig 1B) . We did not attempt to distinguish Langerhans' cells from nonLangerhans' cells or to characterise dermal dendritic cells. Staining of these cells is currently under investigation. Semiautomated quantitation of the length of basement membrane underlying the area of section in which the cells had been counted was made using a VIDS II image analyser. The basement membrane measured included that surrounding islands of papillary dermis which are inevitably included in sections of psoriatic skin. Cell counts were then expressed as cells per unit length of underlying basement membrane.
Significances of difference in cell counts and PASI scores were assessed using Student's two tailed t test and Wilcoxon's rank sum test using the Minitab release 6 (Minitab Inc.) statistics program. The PASI scores and cell counts were correlated using Spearman's rank correlation coefficient (rs).
Means and standard errors were used.
Results

CLINICAL RESPONSE
There was a highly significant reduction in PASI score after a course of cyclosporin for 12 weeks from 13-1 ((SEM) 1-8) to 2.7 (0.7) (p < 0-01) (Wilcoxon's rank sum text). Two of the seven patients in group A had a poor response and the mean reduction in PASI score was only 40%. Ten of the 11 patients in group B had greater than 80% improvement in their PASI scores. The mean PASI score rose significantly in the four weeks after therapy from 2'7 (0 7) to 5.5 (0 9) (p < 0 01) (Wilcoxon's rank sum test). One month after Effects of oral cyclosporin on epidermal cells in psoriasis Figure 2 
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(B) There were equal numbers of keratinocytes positive for CD29 in both affected and unaffected skin and these were not significantly affected by cyclosporin. 21 :n of CD18 The proportion of dendritic cells which are correlated CD1 positive is decreased in psoriatic epiderme and one mis when compared with normal epidermis.'8 been with-To exclude CD1 negative cells is relevant iificant cor-because these cells are crucial in the mixed 154 and the lymphocyte response and presumably also in antigen presentation in vivo. 22 Other workers have shown that 14 days of cyclosporin reduces preferentially the number of epidermal CD1 negative cells compared with CD1 gs such as positive cells as well as the overall activity of luction of y antigen presenting cells.2' 23 CD18 is duction of expressed by lymphocytes but their smaller lic and self-size and lack of dendrites means they can be T lympho-easily excluded from the cell counts. As sis to allow recently shown in a smaller study using state.'4 It is cyclosporin for only two weeks, we confirm decreased that CD18 positive dendritic cells usually are ory cells in decreased in psoriatic epidermis after ,ded by loss cyclosporin treatment.9 16 
